483 Roundup: Six Firms Flagged for Variety of Violations By Sam | February 15, 2018 The FDA issued Form 483 reports to facilities in Germany, China, Mexico, South Korea, the United Kingdom and the U.S. for a range of nonconformance issues. Source: Drug GMP Report Posted in Drug GMP Report